Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Broderick

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|February 14, 2021
Commentary: Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?Stephen R Broderick
Thoracic Surgery Clinics|December 5, 2012
Hemothorax: Etiology, diagnosis, and managementStephen R Broderick
Seminars in Thoracic and Cardiovascular Surgery|February 24, 2018
Sublobar Resections-the Margins Justify the MeansStephen R Broderick
Thoracic Surgery Clinics|April 25, 2020
Adjuvant and Neoadjuvant Immunotherapy in Non-small Cell Lung CancerStephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|March 13, 2016
When in doubt … ask the patient: Patient-reported measures and prognosis in esophageal cancerStephen R Broderick
The Annals of Thoracic Surgery|December 22, 2019
Invited CommentaryStephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|November 15, 2017
Neuroendocrine tumors of the lung: Has the stage been set?Stephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|February 16, 2020
Commentary: Chemo if you can-disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non-small cell lung cancerAlexis Chidi, Stephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|April 15, 2022
Commentary: Perioperative systemic therapy in early-stage non-small cell lung cancer: The future is brightAlexis P Chidi, Stephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|November 25, 2020
Commentary: Defining HSR: Health services research or healthy skepticism remainsAlexis P Chidi, Stephen R Broderick
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Thoracic and Cardiovascular Surgery|February 14, 2021
Commentary: Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?Stephen R Broderick
Thoracic Surgery Clinics|December 5, 2012
Hemothorax: Etiology, diagnosis, and managementStephen R Broderick
Seminars in Thoracic and Cardiovascular Surgery|February 24, 2018
Sublobar Resections-the Margins Justify the MeansStephen R Broderick
Thoracic Surgery Clinics|April 25, 2020
Adjuvant and Neoadjuvant Immunotherapy in Non-small Cell Lung CancerStephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|March 13, 2016
When in doubt … ask the patient: Patient-reported measures and prognosis in esophageal cancerStephen R Broderick
The Annals of Thoracic Surgery|December 22, 2019
Invited CommentaryStephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|November 15, 2017
Neuroendocrine tumors of the lung: Has the stage been set?Stephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|February 16, 2020
Commentary: Chemo if you can-disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non-small cell lung cancerAlexis Chidi, Stephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|April 15, 2022
Commentary: Perioperative systemic therapy in early-stage non-small cell lung cancer: The future is brightAlexis P Chidi, Stephen R Broderick
The Journal of Thoracic and Cardiovascular Surgery|November 25, 2020
Commentary: Defining HSR: Health services research or healthy skepticism remainsAlexis P Chidi, Stephen R Broderick
Pageof 5